Ledger.Open graph →

SEC Form D · filed February 19, 2025

Matinas BioPharma Holdings, Inc

Offering

$3.3M

Sold

$1.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BEDMINSTER, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jerome Jabbour · BEDMINSTER, NJExec · Director Robin Smith · Cary, NCDirector Eric Ende · BEDMINSTER, NJDirector Evelyn D'An · Sydney, Channel IslandsDirector Keith Kucinski · BEDMINSTER, NJExec Matthew Wikler · BEDMINSTER, NJDirector Natasha Giordano · Hoboken, NJDirector Robin Smith · Aliso Viejo, CADirector Eric Ende · BEDMINSTER, NJDirector Jerome Jabbour · Tarpon Springs, FLExec · Director Evelyn D'An · Sydney, Channel IslandsDirector Keith Kucinski · BEDMINSTER, NJExec Matthew Wikler · BEDMINSTER, NJDirector Natasha Giordano · HOUSTON, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗